The American Journal of Managed Care1d
FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...
The Washington Post23d
Classified information is out in the open. There’s no need to panic.
the agency’s Information Security Oversight Office (ISOO) determined that there was no threat and that the records could remain public. These documents are among at least 100 instances in which ...